-
My Account
In App
My Account
BSE Live
Oct 28, 16:01Prev. Close
1458.40
Open Price
1460.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 28, 15:59Prev. Close
1457.70
Open Price
1457.70
Bid Price (Qty.)
1432.00 (24)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Concord Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | |
| 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 494.55 | 412.57 | |
| Net CashFlow From Operating Activities | 244.52 | 265.47 | |
| Net Cash Used In Investing Activities | -159.99 | -154.61 | |
| Net Cash Used From Financing Activities | -98.77 | -99.21 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -14.24 | 11.64 | |
| Cash And Cash Equivalents Begin of Year | 15.14 | 3.50 | |
| Cash And Cash Equivalents End Of Year | 0.90 | 15.14 |
22.08.2025
Concord Biotech Standalone June 2025 Net Sales at Rs 203.99 crore, down 5.47% Y-o-Y
12.06.2025
Concord Biotech Standalone March 2025 Net Sales at Rs 429.88 crore, up 34.77% Y-o-Y
05.06.2025
Concord Biotech Consolidated March 2025 Net Sales at Rs 429.88 crore, up 34.77% Y-o-Y
04.03.2025
Concord Biotech Consolidated December 2024 Net Sales at Rs 244.22 crore, up 1.42% Y-o-Y
